# Special Drug Use Surveillance on Long-term Use of Sodium Risedronate Tablets (Benet 75 mg Tablets) (12-month Treatment Survey)

> **NCT02089997** · — · COMPLETED · sponsor: **Takeda** · enrollment: 3304 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Sodium Risedronate

## Key facts

- **NCT ID:** NCT02089997
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-27
- **Primary completion:** 2016-04-30
- **Final completion:** 2016-04-30
- **Target enrollment:** 3304 (ACTUAL)
- **Last updated:** 2018-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02089997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02089997, "Special Drug Use Surveillance on Long-term Use of Sodium Risedronate Tablets (Benet 75 mg Tablets) (12-month Treatment Survey)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02089997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*